Scale with AI Kanda has recently expanded capabilities by acquiring Kupsilla and is recognized as a leading AI automation specialist, signaling a strong opportunity to upsell AI-driven product development, AI engineering, and automation services to existing clients seeking scalable AI solutions.

Awarded deployments Recent Globee awards for IT deployments and customer success indicate proven excellence in complex deployments; leverage these credentials to target enterprise buyers prioritizing reliable deployment success and post-implementation support.

Two-shore advantage Two-shore delivery with US business analysis and European/Latin American execution creates a cost-efficient, high-speed model attractive to mid-market and enterprise clients seeking global delivery without sacrificing quality.

Industry reach Active engagement with health tech and biotech events and partnerships positions Kanda to cross-sell software product development, regulatory-compliant solutions, and cloud deployments to biotech, life sciences, and biomedicine firms.

Strong revenue signals Revenue range of 100M–250M and a track record of billions in client revenue generated imply solid financial health and capacity to take on larger, long-term engagements with strategic clients and platform-scale programs.